web counter
LEXO PA REKLAMA!

SHKARKO APP

App Store
Google Play

WHO recommends drugs like Ozempic for long-term obesity treatments

2025-12-01 22:08:00, Shëndeti CNA

WHO recommends drugs like Ozempic for long-term obesity treatments

The World Health Organization has published guidelines recommending GLP-1-type drugs as long-term treatments for obesity.

Ozempic-style drugs have been approved as long-term treatments for obesity under new guidelines published by the WHO, which has called on governments and health systems around the world to ensure the treatment is more affordable and universally accessible.

However, the WHO warned that even with rapid expansion of production, weight loss drugs are projected to reach less than 10% of those who could benefit by 2030.

"Obesity is a major global health challenge that WHO is committed to addressing by supporting countries and people around the world to control it effectively and equitably," said WHO Director-General Tedros Adhanom Ghebreyesus.

In response to what it describes as a growing public health challenge, the WHO has drawn up guidelines on the use of glucagon-like peptide-1 (GLP-1)-based medications, such as Ozempic or Wegovy, for people with obesity.

Published overnight in the Journal of the American Medical Association (JAMA), the guidelines recommend that long-term GLP-1 therapies be used for weight management for adults with obesity along with behavioral therapy, such as physical activity, diet and regular counseling sessions. /CNA





Lajmet e fundit nga